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Abstract Ecthyma gangrenosum, presenting as embolic
lesions caused by Pseudomonas aeruginosa infection, has
distinct pathognomonic features and a high mortality rate
in patients with bacteremia, but when recognized early is
easily treated. In this case report we describe this dissem-
inated infection in an adult patient treated with chemo-
therapy for an astrocytoma.
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Introduction
Lesions of the skin are common in cancer patients, usually
occurring in the context of paraneoplastic skin events such
as erythema nodosum and dermatological alterations due to
allergic reactions or the side effects of systemic antitumor
therapy, or in the context of erysipelas or cellulitis caused
by either Streptococcus or Staphylococcus. However, in
patients with chemotherapy-induced neutropenia (defined
as \500 functional polymorphonuclear leukocytes/ll),
innocent-looking macules or papules may be the first signs
of sepsis with uncommon organisms.
Ecthyma gangrenosum is a rare cutaneous infection with
painless, round, necrotic lesions consisting of a central
black or gray-black eschar with surrounding erythema. The
lesions are usually localized in nonpressure areas (in con-
trast to ischemic lesions), such as the extremities and
gluteal and perineal regions. Solitary lesions have a better
prognosis than multiple lesions, the latter being commonly
related to life-threatening Pseudomonas aeruginosa bac-
teremia. Further, the prognosis is determined by an early
diagnosis, the duration of neutropenia, and the start of
appropriate antibiotic treatment. Predisposing factors, such
as chemotherapy, extensive burns, hypogammaglobuline-
mia, hematological malignancies, and comorbidities (e.g.,
diabetes mellitus and malnutrition), contribute to the
severity of the immunodeficient status, and thus negatively
to the outcome [1]. Mortality rates of Pseudomonas sepsis
in immunocompromised persons range from 38 to 96%,
whereas the mortality rate in nonbacteremic patients is
15.4% [2]. The reported high mortality rate could be
diminished by timely recognition of the early occurring
pathognomonic characteristics of ecthyma gangrenosum,
so that appropriate systemic antibiotic therapy can be
initiated.
Case report
A 37-year-old Caucasian man with a history of low-grade
oligo-astrocytoma in the right temporo-parietal lobe pre-
sented in October 2008 with epileptic insults, sensory
neuropathy in the left hand, and coordination dysfunction
of the left leg. Computed tomography (CT) of the brain
showed progressive disease with an increase in size of the
known lesion. As radiation therapy had previously been
given, with a total dose of up to 50 Gy on the tumor site,
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this was not an option anymore. Therefore, chemotherapy
was opted for, and PVC chemotherapy, consisting of
lomustine 110 mg/m2 on day 1, procarbazine 60 mg/m2 on
days 8–21, and vincristine 1.4 mg/m2 on days 8 and 29, to
be repeated every 6 weeks, was started in November 2008.
Further relevant comedication consisted of dexamethasone
2 mg, levetiracetam 1500 mg, valproate 1500 mg, and
clobazam 10 mg, all twice daily. On the evening of day 40
of the first course, he was admitted with febrile neutropenia
and cold chills. He had no worsening of his neurological
symptoms. There were no localizing complaints. At physical
examination blood pressure measured 139/69 mmHg with
a pulse of 109 beats per min and a temperature of 38.5C.
On his arms, legs, abdomen, and pubic area several
hemorrhagic bullous lesions with surrounding erythema
were observed, some with central black necrosis (Figs. 1,
2). There were no other physical signs of possible infec-
tion found. Laboratory results showed 6.6 mmol/l hemo-
globin (normal values 8.6–10.5 mmol/l), less than
0.05 9 109/l neutrophils (normal values 1.4–8 9 109/l),
and 63 9 109/l thrombocytes (normal values 150–370 9
109/l), with 60 mg/dl C-reactive protein (maximum value
in hospitalization period 170 mg/dl; normal values
0–9 mg/dl). Syndrome of inappropriate antidiuretic hormone
secretion by central nervous malignancy was observed,
with 125 mmol/l sodium (normal values 136–145 mmol/l)
and 260 mOsm/kg serum osmolality (normal values
270–300 mOsm/kg). After several pictures of the skin
lesions had been put on a secure intranet link, a derma-
tologist was consulted by phone, and suggested sampling
bacterial cultures of skin and bullous fluid. Bacteriological
sampling was taken from blood, urine, skin, and bullous
fluid. Because of the patient’s neutropenic fever, we
started imipenem/cilastatin 500/500 mg four times daily,
intravenously, after the sampling. A day later, the con-
sulted dermatologist examined the patient. At that time,
the clinical picture, combined with positive culture of
Pseudomonas aeruginosa, was typical for the diagnosis of
ecthyma gangrenosum caused by disseminated Pseudomonas
infection, and therefore histology of the skin lesions was not
obtained. The antibiotic treatment was switched from
imipenem/cilastatin to ceftazidime 1 g six times a day and
tobramycin 7 mg/kg according to tobramycin blood levels,
given intravenously [3, 4]. The clinical condition improved
after 3 days of hospitalization, the fever subsided after 1 day
of this antibiotic treatment, and the neutrophils were
restored to a normal level in 9 days. After 1 week, the
antibiotics were switched to ciprofloxacin 750 mg bid for
1 week, given orally, and the patient could be discharged.
In the second chemotherapy course, lomustine and
procarbazine were reduced to 75% of the original dose,
and the patient remained without a recurrent neutropenic
episode.
Discussion
Ecthyma gangrenosum is a cutaneous entity that is classi-
cally associated with septicemia and gram-negative bac-
teremia caused by Pseudomonas aeruginosa in
immunocompromised patients. Usually, this disseminated
cutaneous infection presents with embolic lesions with the
formation of bullae. The exact mechanism of pathogenesis
of this disease in a neutropenic patient is poorly under-
stood. The Pseudomonas organism releases a variety of
proteases in outer-membrane derived vesicles, regulated by
a quorum sensing system. The virulence of these patho-
genic factors leads to invasion of the medial and adventitial
layers of the vascular wall of nearby blood vessels,
resulting in septicemia, bacteremia, embolization, and
dissemination [5, 6]. After invasion of the subcutaneous
tissue, the bacilli are usually found in the collagen bundles
of the dermis and panniculus [7]. Proliferation of the
Fig. 1 Lesion with central black necrosis and surrounding erythema
in pubic area
Fig. 2 Hemorrhagic bullous lesion with surrounding erythema on the
wrist
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organisms leads to the production and release of exotoxin
A and proteases, resulting in the formation of bullae and
ulceration. As the diagnosis in our patient was already clear
from the positive bacterial culture of the bullous fluid,
histology was not performed, but would typically show
necrotizing hemorrhagic vasculitis with bacterial infiltra-
tion into the media and adventitia of vessels resulting in
skin necrosis. The lesions are usually situated in the gluteal
and perineal region, but can spread to the trunk and
extremities and in extreme cases even to the face. Differ-
ential diagnosis includes pyoderma gangrenosum, other
forms of vasculitis, and the presence of cryoglobulins or
septic emboli from other microorganisms (Escherichia
coli, Aeromonas hydrophilia, Pseudomonas cepacia, Can-
dida, Fusarium species, and Aspergillus species).
Major risk factors for the development of ecthyma
gangrenosum, such as chemotherapy, extensive burns,
hypogammaglobulinemia, hematological malignancies,
and comorbidities (e.g., diabetes mellitus and malnutri-
tion), are all associated with an immunocompromised
condition [2]. The combination of these different risk
factors contributes to a life-threatening situation with a
high mortality rate in the case of a systemic infection.
Mortality rates vary from 38 to 96% in patients with bac-
teremia, and are approximately 15% in patients with a
nonbacteremic condition. Multiple skin lesions predict a
worse prognosis and can be diagnosed in both septicemic
and nonsepticemic patients. However, ecthyma gangreno-
sum caused by Pseudomonas aeruginosa can develop in
only a small number of cases in the absence of bacteremia
[8, 9]. The recommended treatment for both bacteremic
and nonbacteremic ecthyma gangrenosum combines an
anti-pseudomonas b-lactam antibiotic or a third-generation
cephalosporin with an aminoglycoside, sometimes even
with surgical debridement [3, 4].
The diagnosis in our patient was made within less than
48 h. This, in combination with an early alert of the patient
concerning the febrile episode, may have explained the fact
that blood cultures remained negative. Another explanation
may be the small number of bacilli present in the blood-
stream needed to induce a systemic infection. As ecthyma
gangrenosum has a distinctive presentation, a favorable
outcome can be achieved when it is treated in a timely
fashion with appropriate antibiotics.
As far as we know, ecthyma gangrenosum has mostly
been reported in leukemic patients or children with solid
tumors. In one study of a small series of women with breast
cancer, and in another retrospective study of 111 patients
with various solid tumors, ecthyma gangrenosum was
described in patients being treated with chemotherapy
[10, 11]. The retrospective study revealed a declining
incidence of ecthyma gangrenosum in these patients over
the course of years. Our case report reminds the reader of
this disseminated infection in an adult patient being treated
with chemotherapy for an astrocytoma. A number of risk
factors, i.e., a combination of chemotherapy and dexa-
methasone leading to a neutropenic period of 1 week,
culminated in this case of ecthyma gangrenosum. As in our
case, timely recognition is important; in our patient this
was possible by early culturing and recognition of the
clinical picture so that adequate measures could be taken
subsequently.
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